WHO to meet next week to consider emergency use listing of India’s Covaxin
The Hindu
Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI to the World Health Organisation on April 19 for its vaccine.
The WHO’s technical advisory group will meet on October 26 to consider the emergency use listing of India’s Covaxin which is being used in the country’s nationwide anti- vaccination programme, according to the global health agency’s chief scientist Soumya Swaminathan.
Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the World Health Organisation on April 19 for its vaccine.
Ms. Swaminathan, the WHO’s Chief Scientist, said on Twitter on Sunday that the technical advisory group will meet on October 26 to consider the Emergency Use Listing (EUL) for Covaxin.